Myriad Genetics (NASDAQ:MYGN)

investor research

Top Analyst Upgrades and Downgrades: AOL, Echelon, Fairway Group, LinkedIn, Lululemon, More

February is turning out to be volatile after a down January, and now investors and analysts are positioning themselves for the year ahead. 24/7 Wall St. reviews dozens of Wall ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: Arch Coal, ADM, Citigroup, Myriad, Sirius and More

February is acting as though it wants to carry on in January's volatility and downward momentum for stocks. Earnings season also created selective winners and losers. 24/7 Wall St. reviews dozens ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Gilead, Teva, Textura, Twitter and More

Stocks have been hitting ever higher highs going into year-end. Now investors have to be wondering how to position their portfolios for 2014 and beyond. 24/7 Wall St. reviews many ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades, Stocks to Sell: Ariad, Goodyear, Myriad, Kellogg and More

Stocks are at all-time highs now that a deal has been reached in Washington, D.C., and investors have to wonder which stocks are set to keep rising and which ones ...
Read Full Story »
Bull and Bear figures

Closing Bell for Friday on Wall Street: Markets Open Lower, Trail South All Day

U.S. equity markets opened lower this morning, kicking off a gradual decline that lasted all day. Profit-taking and a lower-than-expected reading on consumer sentiment in the U.S. get the blame. ...
Read Full Story »
Bull and Bear

Top 10 Analyst Upgrades and Downgrades: ADP, GameStop, Myriad, SolarCity and More

Investors and traders are frequently looking for fresh research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls to find great ideas ...
Read Full Story »
biotech

Supreme Court Justices Unanimous on Denying Patents for Human Genes

The U.S. Supreme Court issued a unanimous 9-0 ruling today denying patent protection from human genes isolated from the body. In its ruling, the court also ruled that synthetic molecules ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Brocade, Garmin, Myriad, Yum! Brands, More

Investors and traders are always searching for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to ...
Read Full Story »
Wall St Bull statue

Top 12 Analyst Upgrades and Downgrades: Calpine, CME, CVS, Panera and More

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall ...
Read Full Story »
biotech

Myriad Genetics, Angelina Jolie and Genomics in Focus

Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic test using Myriad's gene sequencing tested positive for the ...
Read Full Story »
health care

Jefferies Stocks to Buy: Big Gains in Life Sciences and Diagnostics

In theory, medical technology companies should be some of the market’s best-performing stocks. After all, it’s not really a cyclical business, and price tags are rarely a stumbling block when ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Home Depot, Lululemon, Myriad Genetics and More

Investors and traders are always on the lookout for fresh Wall Street research ideas of stocks to buy, value stocks and dividend stocks. 24/7 Wall St. reviews many fresh research ...
Read Full Story »
biotech

Gene Patent Showdown for Myriad Comes to a Head

Should a company get to patent your genetic DNA? That is the question when it comes to Myriad Genetics Inc. (NASDAQ: MYGN). This company and its stock are at the ...
Read Full Story »
Wall St Bull statue

Bank of America Merrill Lynch Unveils Secular Growth Stock Buy List (BAC, PETM, HLF, MYGN, ACT, SAH, HEI, FEIC, LOPE)

The negative fourth-quarter gross domestic product (GDP) reading of -0.1% caught most Wall St. analysts and economists by surprise. This unforeseen number was skewed by a huge decrease in government ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ACC, AAPL, BUD, CLS, CHKP, DLTR, DD, FB, MYGN, NOK, NSC, PVA, SEP, UTHR, WHR, KSU, HIG, ATVI, INTC, TWX)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research notes this Wednesday. American Campus Communities Inc. (NYSE: ACC) raised to Buy at UBS. ...
Read Full Story »